PRESENTED BY: Dr. Bonnie Hennig-Trestman, Dr. Mary Edmondson, Dr. Myriam Sollmon, and Dr. Claudia Testa
Ask the Experts
HD Experts will answer your questions about Huntington’s disease. Submit a question when you register for the conference.
Clinical Neuropsychologist, Univ. Of SC School of Medicine
Dr. Myriam Sollman, PhD, is a clinical neuropsychologist who specializes in movement disorders and dementia. In her work, Dr. Sollman helps patients & family to understand one’s strengths and weaknesses, and to identify ways to improve daily life. In the HD community, Dr. Sollman provides assessment and education services to both preclinical and clinically manifesting individuals.
Dr. Sollman received her training at the University of Kentucky, the University of Florida, and the Barrow Neurological Institute. She began her career here in NC at the Wake Forest School of Medicine, where she helped build the neuropsychology program. She is now Associate Professor at the University of SC School of Medicine. Dr. Sollman is active with HD Reach and looks forward to providing more opportunities for learning!
Founder, HD Reach
Dr. Mary Edmondson is a psychiatrist, internist, and founder of HD Reach. Having watcher her father succumb to HD, Mary is committed to ensuring HD patients receive the care they need. Mary’s expertise in the psychiatric care of HD patients is well known locally in North Carolina, the US and in Europe.
Professor, Neurology, Virginia Commonwealth University
Claudia Testa, MD, PhD is a Professor in the Department of Neurology at Virginia Commonwealth University (VCU) and serves as medical director for the VCU Parkinson's and Movement Disorders Center (PMDC) and Joan Massey Chair in Clinical Parkinson Disease. She is the founding director of the Huntington Disease (HD) Program and Huntington Disease Society of America Center of Excellence at VCU. Dr. Testa earned an undergraduate degree in biophysics from the Johns Hopkins University, and MD and PhD degrees from University of Michigan with PhD work in the Anne Young / Jack Penney lab. She completed a movement disorders fellowship at Emory University working in HD clinical trials and basic research Parkinson disease model systems, and later joined the faculty. Dr. Testa now has over twenty years of experience in clinical research, including serving as global co-PI for a suite of Huntington Study Group (HSG) clinical trials that culminated in the FDA approval for deutetrabenazine, the second compound approved for an HD indication and the first deuterium modified therapeutic compound. Dr. Testa has served on the HSG executive committee and HSG scientific advisory committee, and on the International Parkinson and Movement Disorders Society task force on definitions of HD.
Director of Carilion Clinic Huntington's Disease Program at Carilion Clinic
Dr. Bonnie Hennig-Trestman has over 30 years of expertise providing and guiding clinical services to patients and family members suffering from neurodegenerative, physical, and psychiatric illnesses. She is the Director of the Carilion Clinic Huntington’s Disease Program in Roanoke, Virginia; Assistant Professor at Virginia Tech Carilion School of Medicine in the Department of Basic Science Education; and the Special Programs Director at HD Reach in Raleigh, NC. She has over two decades of experience working with people who are impacted by Huntington’s Disease.
Dr. Hennig-Trestman conducts both observational and clinical trial research related to HD. In 2003 she wrote a book called, “Talking to Kids About HD”. It has been translated into multiple languages and was revised in 2018. Dr. Hennig-Trestman has provided educational lectures on various topics related to HD to national and international audiences. She is a member of the Huntington Study Group (HSG), the European HD Network (EHDN), and serves on the Board of Directors as the Research Co-Chair for Huntington’s Disease Youth Organization (HDYO).